GI
TWST icon

GAMMA Investing’s Twist Bioscience TWST Stock Holding History

GAMMA Investing’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$256K Buy
1,327
+384
+41% +$47.4K 0.01% 1144
2026
Q2 		$97K Buy
943
+185
+24% +$12K ﹤0.01% 1834
2026
Q1 		$36K Buy
758
+262
+53% +$11.7K ﹤0.01% 2400
2025
Q4 		$15.7K Buy
496
+239
+93% +$7.46K ﹤0.01% 2741
2025
Q3 		$7.23K Buy
257
+28
+12% +$848 ﹤0.01% 3034
2025
Q2 		$8.43K Sell
229
-519
-69% -$17.9K ﹤0.01% 2898
2025
Q1 		$29.4K Buy
748
+303
+68% +$13.6K ﹤0.01% 2173
2024
Q4 		$20.7K Buy
445
+170
+62% +$7.68K ﹤0.01% 2249
2024
Q3 		$12.4K Sell
275
-3,479
-93% -$166K ﹤0.01% 2362
2024
Q2 		$185K Buy
3,754
+3,566
+1,897% +$145K 0.03% 523
2024
Q1 		$6.45K Buy
188
+18
+11% +$650 ﹤0.01% 2292
2023
Q4 		$5.51K Buy
+170
New +$3.93K ﹤0.01% 2195

Other funds holding TWST

MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's TWST Position: Q3 2026 in Review

GAMMA Investing increased its Twist Bioscience (TWST) stake by 41% in Q3 2026, buying an estimated $47.4K and bringing the position to 1,327 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #1144.

GAMMA Investing first reported a position in TWST in Q4 2023 and has held it in 12 quarters since. 7 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • GAMMA Investing held 1,327 shares of Twist Bioscience worth $256K as of Q3 2026.
  • GAMMA Investing bought 384 Twist Bioscience shares in Q3 2026, an estimated $47.4K.
  • Twist Bioscience made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1144 holding.
  • GAMMA Investing first reported a position in Twist Bioscience in Q4 2023 and has held it in 12 quarters since.
  • 7 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.